基本信息
林汉斌  男  硕导  中国科学院上海药物研究所
电子邮件: linhanbin@simm.ac.cn
通信地址: 上海市浦东新区祖冲之路555号
邮政编码:

招生信息

   
招生专业
100706-药理学
招生方向
心血管药理学
免疫学
病理学

教育背景

2010-09--2014-10   萨斯喀彻温大学   药理学博士
2006-09--2010-07   北京理工大学   理学学士

工作经历

   
工作简历
2014-11~2021-01,渥太华心脏研究所, 博士后
2010-09~2014-10,萨斯喀彻温大学, 药理学博士
2006-09~2010-07,北京理工大学, 理学学士
社会兼职
2012-10-01-今,Member of Canadian Cardiovascular Society,
2012-07-08-今,Member of CIHR Institute of Circulatory and Respiratory Health (ICRH) research,

教授课程

药理学(英语授课)
生理学(英语授课)
生物化学实验课(英语授课)
分子生物学实验课

专利与奖励

   
奖励信息
(1) European Society of Cardiology Congress 2017 young investigator award, , 其他, 2017
(2) Ottawa Heart Institute Cardiac Research Endowed Fellowship, , 研究所(学校), 2017
(3) 国家优秀自费留学生奖学金, , 部委级, 2014
(4) Arthur Symth PhD Scholarship, , 研究所(学校), 2013
(5) Canadian Institutes of Health Research Have a Heart Bursary, , 国家级, 2012
(6) James Regan Graduate Scholarship Award in Cardiology Research, , 研究所(学校), 2012

出版信息

   
发表论文
(1) COVID-19 and the Heart, ACE2 Level and the Company it Keeps Hold the Key, JACC: Basic to Translational Science, 2020, 第 1 作者
(2) Innate immune Nod1/RIP2 signaling is essential for cardiac hypertrophy, - but requires mitochondrial antiviral signaling protein (MAVS) for signal transductions and energy balance, Circulation, 2020, 第 1 作者
(3) Protection of the Transplant Kidney from Preservation Injury by Inhibition of Matrix Metalloproteinases, PLoS One, 2016, 第 3 作者
(4) Subthreshold nitric oxide synthase inhibition improves synergistic effects of subthreshold MMP-2/MLCK-mediated cardiomyocyte protection from hypoxic injury, Journal of Cellular and Molecular Medicine, 2016, 第 2 作者
(5) Inhibition of MMP-2 expression with siRNA increases baseline cardiomyocyte contractility and protects against simulated ischemic reperfusion injury, BioMed Research International, 2014, 第 1 作者
(6) Inhibition of MMP-2 expression affects the levels of metabolic enzymes: Proteomic analysis of rat cardiomyocytes. Journal of Proteomics, Journal of Proteomics, 2014, 第 1 作者
(7) Synergy in protection against cardiac ischemia/reperfusion injury: a novel therapeutic paradigm for the future, Future Medicinal Chemistry, 2013, 第 3 作者
(8) Proteomic analysis of right and left cardiac ventricles under aerobic conditions and after ischemia/ reperfusion, Proteomics, 2012, 第 1 作者
(9) Effect of the myosin light chain kinase inhibitor ML-7 on the proteome of hearts subjected to ischemia/reperfusion injury., Journal of Proteomics, 2012, 第 1 作者
发表著作
( 1 ) 染色体17q12微缺失指南, 17q12 microdeletions, Unique 及 施乐(英国)信托基金, 2021-01, 第 1 作者

科研活动

   
科研项目
( 1 ) 探索免疫蛋白因子在心血管疾病药理和病理机制中的调控作用, 负责人, 地方任务, 2021-03--2026-02
参与会议
(1)INNATE IMMUNE NOD1/RIP2 SIGNALING IS ESSENTIAL FOR CARDIAC HYPERTROPHIC RESPONSE – WITH A SURPRISING CRITICAL INTERACTION WITH MITOCHONDRIAL DANGER ACTIVATOR   2017-08-25
(2)INNATE IMMUNE NOD1/RIP2 SIGNALING IS ESSENTIAL FOR CARDIAC HYPERTROPHIC RESPONSE – WITH A SURPRISING CRITICAL INTERACTION WITH MITOCHONDRIAL DANGER ACTIVATOR   2016-10-15
(3)Canadian Cardiovascular Congress   2012-10-06
(4)Inhibition of MMP-2 expression with siRNA increases cardiomyocyte contractility   2012-07-12